A63T (p.Ala63Thr) variant of PON1 (Serum paraoxonase/arylesterase 1)
A63T (p.Ala63Thr) in PON1 (Serum paraoxonase/arylesterase 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
A63T (p.Ala63Thr) variant details
- p.Ala63Thr
- rs1302207706
- NCI-TCGA Cosmic COSV5593
- TOPMed rs1302207706
- Variant assessed as somatic; moderate impact.
- Missense
- MutPred 0.53
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available